[The transparency commission: evaluation and re-evaluation].
OBJECTIVE
The purpose of the French Transparency Commission is to provide scientific advice concerning the usefulness, interest and good use of drugs.
The work of the Transparency Commission lies at the interface between the French or European marketing approval procedures and the health and economic prerequisites of the French community.


RESULTS
The opinion of the French Transparency Commission is used to assess the medical service provided by a new drug and the improvement of this medical service subsequent to its use. This opinion is taken into consideration for establishing the reimbursement rate applied by the social security organizations and the selling price set by the administration. The expert opinions and recommendations established by the Transparency Commission participate in implementing good use of drugs.
Bergmann
J F
JF
Service de Médecine, Hôpital Lariboisière, 2, rue Ambroise Paré, F75475 Paris. jf.bergmann@lrb.ap-hop-paris.fr
D017277:Drug Approval; D016527:Drug Costs; D004345:Drug Industry; D005602:France; D006801:Humans; D007349:Insurance, Health, Reimbursement; D008389:Marketing of Health Services